Charco Neurotech sponsors Walk for Parkinson’s 2024 fundraising series

Around 153,000 people in the UK are living with Parkinson’s, a condition with more than 40 symptoms that extend beyond the well-known tremors to include severe muscle spasms, anxiety and depression. Parkinson’s UK has been at the forefront of addressing these challenges, providing support and spearheading research aimed at finding a cure.

Since its inception in 2015, Walk for Parkinson’s has seen over 30,000 participants across the UK join the movement to raise awareness and funds. An additional 1,600 supporters have engaged virtually since the pandemic, showcasing the dedication of the Parkinson’s community.

The Walk for Parkinson’s series will take place at 15 locations across the UK between June and October; Parkinson’s UK invites individuals of all ages and abilities to sign up and help the charity stride towards life-changing research. Each event will offer two distances for participants to choose from; a shorter, fully accessible option and a longer route.

Charco Neurotech will be present at each walk so attendees can find out more about its products. For more on Walk for Parkinson’s, to sign up to walk or volunteer, visit: parkinsons.org.uk/get-involved/walk-parkinsons

Paul Jackson-Clark, Director of Fundraising & Experience at Parkinson’s UK, said: “We are delighted to have Charco Neurotech as our sponsor this year. Walk for Parkinson’s is crucial not only for fundraising but also for bringing our community together.

"There's no cure for Parkinson’s as yet. But if we walk together we can make a difference to the lives of people with Parkinson’s. We can make breakthroughs. We can find a cure.”

Lucy Jung, CEO of Charco Neurotech, added: “This sponsorship allows us to connect directly with the community we support and to share our commitment to bring smiles back for people with Parkinson’s and their loved ones. Together, we aim to make a tangible impact through innovation and solidarity.”

Charco Neurotech's CUE device - developed by a team of designers, engineers, and clinicians - utilises pulsed cueing and high-frequency focused vibrotactile stimulation to alleviate symptoms of the disease, including slowness, stiffness, rigidity, freezing of gait and more.

With over 3,000 people using CUE day to day, pilot tests have seen users with Parkinson’s improve their MDS-UPDRS scores by an average of 7.8 points, which is considered clinically significant.

Lucy Jung is a former winner of the Woman Entrepreneur of the Year crown in the Business Weekly Awards; entries for this and all other categories is still open.